Read and report vaccine reactions, harassment and failures.
Prior to the recommendation of routine mumps vaccination, mumps infections most commonly affected children between the ages of 5 and 9 years of age. However, since the mid 1980’s, the demographic of mumps infection in the U.S. has shifted, resulting in a higher risk of mumps infection in older children, adolescents, and young adults. People who travel to high-risk countries where mumps is endemic and those who spend a great deal of time in crowded, confined settings such as daycare centers, schools, college dormitories and military bases, are also at higher risk.
Individuals with compromised immune systems, such as those infected with HIV/AIDS, undergoing chemotherapy treatment for cancer, and those taking oral steroids, may also be at higher risk for contracting mumps infection.
IMPORTANT NOTE: NVIC encourages you to become fully informed about Mumps and the Mumps vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.